Manipulating the natriuretic peptide system for the treatment of pulmonary hypertension

Eitemau Tebyg

• Enhancing natriuretic peptide bioactivity prevents bleomycin-induced pulmonary fibrosis
  gan: Baliga, Reshma S, et al.
  Cyhoeddwyd: (2011)
• Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis
  gan: Baliga, R S, et al.
  Cyhoeddwyd: (2014)
• New perspectives for the treatment of pulmonary hypertension
  gan: Baliga, Reshma S, et al.
  Cyhoeddwyd: (2011)
• Synergy between Natriuretic Peptides and Phosphodiesterase 5 Inhibitors Ameliorates Pulmonary Arterial Hypertension
  gan: Baliga, Reshma S., et al.
  Cyhoeddwyd: (2008)
• Inhibition of Phosphodiesterase 2 Augments cGMP and cAMP Signaling to Ameliorate Pulmonary Hypertension
  gan: Bubb, Kristen J, et al.
  Cyhoeddwyd: (2014)